Search results
Results from the WOW.Com Content Network
With the milestone of a $1 billion settlement behind them, relatives of the 98 people who died in the Surfside condominium building’s collapse have begun private hearings this week with a Miami ...
The money will be paid out over 18 years and distribution is divided among the state, regions, counties and cities.
Florida is the first state to settle its opioid claims against major pharmacy chains Walgreens and CVS Health Corp, collecting more than $1.1 billion from the two companies. Walgreens reaches $683 ...
Michigan normally has a cap of $280,000 for "noneconomic loss," which is defined as "damages or loss due to pain, suffering, inconvenience, physical impairment, or physical disfigurement, loss of society and companionship, whether claimed under section 29222 or otherwise, loss of consortium, or other noneconomic loss. [32]
cigarette company advertising class action led by plaintiff's attorney Stephen Tillery resulted in $10.1 billion judgement [1] Madison County, Illinois: 2003/2006 Ritalin class action lawsuits: promoting disorder ADHD to increase drug profits: Robbins v. Lower Merion School District
Pain and suffering is the legal term for the physical and emotional stress caused from an injury [1] (see also pain and suffering). Some damages that might come under this category would be: aches, temporary and permanent limitations on activity, potential shortening of life, depression or scarring .
A judge has given final approval to a settlement of more than $1 billion for victims of the 2021 collapse of a Florida beachfront condominium. Judge approves $1.02-billion settlement in deadly ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...